Over the past decade, Oracle stock (NYSE: ORCL) has emerged as a premier capital-return engine, distributing a remarkable ...
Recursion's co-founder and long-serving chief executive, Chris Gibson, has switched to the role of company chair, and will be succeeded in the CEO role by R&D and commercial head Najat Khan. The ...
Market open and close ceremonies take place daily at the Nasdaq MarketSite Studio in Times Square and around the globe. Executives from Recursion (Nasdaq: RXRX), a leading clinical stage TechBio ...
Entering text into the input field will update the search result below Entering text into the input field will update the search result below ...
Recursion Pharmaceuticals, Inc. is a clinical-stage biotechnology company that combines automation, artificial intelligence, machine learning, and in vivo validation capabilities to discover novel ...
S&P 500, Nasdaq close down as Big Tech's soaring AI budgets trigger flight The S&P 500 and the technology-heavy Nasdaq closed lower on Thursday as investors were rattled by the latest earnings reports ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results